Interstitial lung disease induced by gefitinib and Toll-like receptor ligands is mediated by Fra-1

Yuhei Takada(Keio University), Koichi Matsuo(Hiroshima University), Keigo Kobayashi(Osaka Gakuin University), Lionel Gresh(World Health Organization Regional Office for the Americas), Aline Bözec(Center for Rheumatology), Eiji Ikeda(Keio University), Kazuhito Asano(Harvard University Press), Kohki Kamiya(Keio University), Erwin F. Wagner(Medical University of Vienna), Y. Toyama(Keio University Hospital), Masahiro Watanabe(The University of Osaka)
Oncogene
April 4, 2011
Cited by 26


Related Papers